Mesa Laboratories Inc (MLAB)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Mr. Brian David ArchboldSVP of Continuous Improvement | -1.15k | 116.56k | 売り | 101.27 | 3.71k | -23.68% |
| 2026-06-16 | Ms. Lyndsey Crennenインサイダー | -118.00 | 11.95k | 売り | 101.27 | 1.47k | -7.42% |
| 2026-06-16 | Mr. John V. SakysVP, CFO & CAO | -1.22k | 123.85k | 売り | 101.27 | 16.59k | -6.87% |
| 2026-06-15 | Mr. Brian David ArchboldSVP of Continuous Improvement | 2.45k | 255.41k | Derivative Exercise and Retained Stock | 104.08 | 4.86k | 101.95% |
| 2026-06-15 | Mr. Brian David ArchboldSVP of Continuous Improvement | -1.78k | 0.00 | Other Derivative Disposition | 226.72 | 11.85k | -13.06% |
| 2026-06-15 | Mr. John V. SakysVP, CFO & CAO | 2.72k | 282.79k | Derivative Exercise and Retained Stock | 104.08 | 17.81k | 18.00% |
| 2026-06-15 | Mr. John V. SakysVP, CFO & CAO | -3.95k | 0.00 | Other Derivative Disposition | 226.72 | 15.76k | -20.05% |
| 2026-03-10 | Mr. Shiraz S. LadiwalaLead Independent Director | 3.50k | 252.81k | 買い | 72.23 | 8.52k | 69.68% |
| 2026-03-10 | Mr. Mark Christopher CaponeIndependent Director | 1.30k | 99.33k | 買い | 76.35 | 3.43k | 61.14% |
| 2026-03-10 | Mr. R. Tony TripenyIndependent Director | 1.32k | 99.94k | 買い | 76.00 | 5.40k | 32.21% |
| 2025-12-02 | Dr. John J. SullivanChairman of the Board | -2.00k | 0.00 | Other Disposition | - | 70.06k | -2.78% |
| 2025-10-27 | Mr. Gary M. Owensインサイダー | 11.56k | 0.00 | Derivative Exercise and Retained Stock | - | 64.14k | 21.98% |
| 2025-08-15 | Mr. Shiraz S. LadiwalaLead Independent Director | 1.95k | 0.00 | Derivative Exercise and Retained Stock | - | 5.02k | 63.40% |
| 2025-08-15 | Dr. John J. SullivanChairman of the Board | 1.40k | 0.00 | Derivative Exercise and Retained Stock | - | 72.06k | 1.99% |
| 2025-08-15 | Ms. Shannon M. HallIndependent Director | 1.40k | 0.00 | Derivative Exercise and Retained Stock | - | 4.19k | 50.41% |
| 2025-08-15 | Mr. R. Tony TripenyIndependent Director | 1.40k | 0.00 | Derivative Exercise and Retained Stock | - | 4.08k | 52.41% |
| 2025-08-15 | Mr. Mark Christopher CaponeIndependent Director | 1.40k | 0.00 | Derivative Exercise and Retained Stock | - | 2.13k | 193.92% |
| 2025-08-15 | Ms. Jennifer Sadie AlltoftIndependent Director | 1.40k | 0.00 | Derivative Exercise and Retained Stock | - | 4.88k | 40.41% |
| 2025-06-21 | Mr. John V. SakysVP, CFO & CAO | 582.00 | 55.77k | Derivative Exercise and Retained Stock | 95.82 | 15.14k | 4.00% |
| 2025-06-21 | Mr. John V. SakysVP, CFO & CAO | -454.00 | 0.00 | Derivative Exercise and Sale | 95.82 | 15.14k | - |
| 2025-06-21 | Mr. Brian David ArchboldSVP of Continuous Improvement | 459.00 | 43.98k | Derivative Exercise and Retained Stock | 95.82 | 2.41k | 23.56% |
| 2025-06-21 | Mr. Brian David ArchboldSVP of Continuous Improvement | -385.00 | 0.00 | Derivative Exercise and Sale | 95.82 | 2.41k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。